Home / Business and Economy / CVS Health Beats Estimates, Eyes Turnaround Success
CVS Health Beats Estimates, Eyes Turnaround Success
10 Feb
Summary
- CVS Health reported fourth-quarter earnings and revenue exceeding expectations.
- The company reaffirmed its 2026 profit guidance, signaling turnaround progress.
- Full-year profit is projected between $7 to $7.20 per share for 2026.
CVS Health has reported strong fourth-quarter financial results, surpassing analyst expectations for both earnings and revenue. The company has also reaffirmed its 2026 profit guidance, signaling positive momentum in its ongoing turnaround strategy. This financial health marks a significant improvement after a challenging previous year, with CFO Brian Newman stating that "'24 was a tough year for the company. So '25 righted the ship."
The company anticipates full-year profit for 2026 to fall between $7.00 and $7.20 per share, aligning with Wall Street's expectations. Furthermore, CVS Health is maintaining its 2026 revenue guidance of at least $400 billion. This outlook factors in approximately $20 billion in headwinds, partly due to the company's exit from the Affordable Care Act individual exchange market and adjustments in the retail business to lower drug prices.
